Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success

A drug like ABX464 that has a three-pronged approach to treat Covid-19 by inhibiting viral replication. Credit: Shutterstock.



  • ABX464